...
首页> 外文期刊>BMC Medical Imaging >Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma
【24h】

Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma

机译:GD-Eob-DTPA增强MRI的辐射瘤分析预测肝细胞癌中的KI-67表达

获取原文

摘要

Nuclear protein Ki-67 indicates the status of cell proliferation and has been regarded as an attractive biomarker for the prognosis of HCC. The aim of this study is to investigate which radiomics model derived from different sequences and phases of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI was superior to predict Ki-67 expression in hepatocellular carcinoma (HCC), then further to validate the optimal model for preoperative prediction of Ki-67 expression in HCC. This retrospective study included 151 (training cohort: n?=?103; validation cohort: n?=?48) pathologically confirmed HCC patients. Radiomics features were extracted from the artery phase (AP), portal venous phase (PVP), hepatobiliary phase (HBP), and T2-weighted (T2W) images. A logistic regression with the least absolute shrinkage and selection operator (LASSO) regularization was used to select features to build a radiomics score (Rad-score). A final combined model including the optimal Rad-score and clinical risk factors was established. Receiver operating characteristic (ROC) curve analysis, Delong test and calibration curve were used to assess the predictive performance of the combined model. Decision cure analysis (DCA) was used to evaluate the clinical utility. The AP radiomics model with higher decision curve indicating added more net benefit, gave a better predictive performance than the HBP and T2W radiomic models. The combined model (AUC?=?0.922 vs. 0.863) including AP Rad-score and serum AFP levels improved the predictive performance more than the AP radiomics model (AUC?=?0.873 vs. 0.813) in the training and validation cohort. Calibration curve of the combined model showed a good agreement between the predicted and the actual probability. DCA of the validation cohort revealed that at a range threshold probability of 30–60%, the combined model added more net benefit compared with the AP radiomics model. A combined model including AP Rad-score and serum AFP levels based on enhanced MRI can preoperatively predict Ki-67 expression in HCC.
机译:核蛋白Ki-67表明细胞增殖的状态,并被认为是HCC预后的有吸引力的生物标志物。本研究的目的是研究哪种源自钆 - 乙氧基苄基 - 二亚乙基三胺五乙酸(GD-Eob-DTPA) - 培养MRI的不同序列和阶段的辐射瘤模型优于预测肝细胞癌(HCC)中的KI-67表达,然后进一步验证HCC中KI-67表达的术前预测的最佳模型。该回顾性研究包括151(培训队列:N?= 103;验证队列:N?=?48)病理证实的HCC患者。从动脉相(AP),门静脉相(PVP),肝胆相(HBP)和T2加权(T2W)图像中提取辐射瘤特征。使用最小的绝对收缩和选择运算符(套索)正常化的逻辑回归用于选择要构建辐射磁体分数的功能(Rad-Score)。确定了包括最佳Rad-Score和临床风险因素的最终组合模型。接收器操作特征(ROC)曲线分析,德隆测试和校准曲线用于评估组合模型的预测性能。决策治愈分析(DCA)用于评估临床效用。具有更高判定曲线的AP射频模型表明增加了更多的净利润,比HBP和T2W射系模型提供了更好的预测性能。组合模型(AUC?= 0.922 vs. 0.863),包括AP rad-score和血清AFP水平提高了培训和验证队列中的AP射频模型(AUC?= 0.873 vs.0.813)的预测性能。组合模型的校准曲线显示了预测和实际概率之间的良好一致性。验证队列的DCA显示,在30-60%的范围阈值概率下,与AP放射体模型相比,组合模型增加了更多的净利益。基于增强MRI的AP Rad-Score和血清AFP水平的组合模型可以术前预测HCC中的KI-67表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号